Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users

• Published in: Emerging microbes & infections 2013-12, Vol.2 (12), p.e83-9
• Main Authors: Lin, Pi-Han, Lai, Chung-Chih, Yang, Jia-Ling, Huang, Hui-Lin, Huang, Ming-Siang, Tsai, Mao-Song, Yang, Chia-Jui, Cheng, Chien-Ling, Su, Yi-Ching, Chang, Shu-Fang, Liu, Wen-Chun, Hung, Chien-Ching, Chang, Sui-Yuan, Chang, Shan-Chwen
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2222-1751; 2222-1751
• DOI: 10.1038/emi.2013.83

Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) 07_BC has caused serious HIV-1 epidemics among injecting drug users (IDUs) in East Asia. Little is known about the characteristics of the virus and its impact on disease progression among the infected individuals. In this study, we compared immunological progression between 423 IDUs infected with CRF07_BC and 194 men who have sex with men (MSM) with primary subtype B infection, and a representative full-length CRF07_BC molecular clone, pCRF07_BC, was constructed to characterize the virus. We found that IDUs infected with CRF07_BC had significantly slower immunological progression in the Cox proportional hazards model (hazard ratio: 0.30; 95% confidence interval: 0.13-0.69; P=0.004). The constructed recombinant CRF07_BC viruses had a reduced processing of the Gag/Gag-Pol polyproteins, a decreased incorporation of Vpr in the virus particle, tethering of virus particles on the plasma membrane and decreased virus growth kinetics. These phenotypes are related to the unique 7-amino acid deletion in the p6 of CRF07_BC, since complementation of the 7-amino acid in pCRF07_BC could improve the defective phenotypes. In summary, compared with MSM infected with HIV-1 subtype B, IDUs infected with CRF07_BC had slower immunological progression, which is likely correlated with interference of virus particle maturation by the 7-amino acid deletion in p6.